Updated:
Kureha Corporation
Kureha Corporation was established in 1944 as Kureha Chemical Industry, a spin-off from the chemical division of Kureha Spinning, which itself had roots...
Kureha Corporation
Kureha Corporation was established in 1944 as Kureha Chemical Industry, a spin-off from the chemical division of Kureha Spinning, which itself had roots dating to 1934. The company renamed to Kureha Corporation in 2005 to reflect its expanded business beyond chemicals. Its principal product lines include polyvinylidene fluoride (KF Polymer), polyglycolic acid (Kuredux), pitch-based carbon fiber (Kureka), and thermal expansion microcapsules. The pharmaceutical division, born from carbon materials R&D, produces Kremezin and Covalzin for chronic kidney disease patients. The agrochemical unit markets proprietary fungicides metconazole and ipconazole. Geographically, Kureha maintains production sites in Japan and a global network of group companies across Asia, Europe, and the Americas. Kureha is publicly traded on the Tokyo Stock Exchange Prime Market (code: 4023). The company reported its financial results for the fiscal year ended March 2026 on May 12, 2026, alongside a new long-term plan titled "Technology to Value" targeting 2035. Its product development is concentrated in advanced materials, energy-related PGA for shale gas, and healthcare. The company also supplies home-use plastic wrap "New Kure Wrap" and "Kichinto-san" series, as well as the Seaguar fishing line brand. In May 2026, Kureha earned an EcoVadis "Commitment Badge" for sustainability performance. A structural differentiator for Kureha is its vertically integrated chemistry platform — starting from industrial salt and chlorine, the company produces a broad range of downstream specialty products including polymers, pharmaceuticals, and agrochemicals. This base chemistry capability, combined with in-house R&D across multiple sectors, creates a technical moat that ties disparate businesses to a common manufacturing heritage. The company has no external asset management arm or separate investment vehicle; it operates as a single corporate entity with a focus on proprietary technology development and industrialization.
General information
Firm type
other
Year founded
1944
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Principals
Katsuyasu Nakatake
Representative Director and President
Sector focus
Frequently asked questions
Who runs investment decisions at Kureha?
Investment decisions at Kureha are made by the board of directors led by Representative Director and President Katsuyasu Nakatake. The company's capital allocation strategy is disclosed in its annual financial results and long-term plans (per firm website, 2026).
How does Kureha source proprietary deal flow?
Kureha sources technology and product opportunities primarily through its internal R&D network and collaborations with university and industry partners. Its history of developing proprietary materials like polyglycolic acid and polyvinylidene fluoride demonstrates a technology-driven rather than acquisition-led growth strategy (per firm website, 2025).
Is Kureha structured as a family office or does it operate more like an industrial firm?
Kureha is a publicly traded joint-stock company listed on the Tokyo Stock Exchange Prime Market. It functions as an industrial manufacturer and technology developer, not as a family office or investment vehicle. The firm has no separate asset management arm and does not deploy capital as a fund or direct investment firm (per firm website, 2025).
Does Kureha participate in fund commitments or only direct deals?
Kureha does not act as a limited partner in external funds or participate in direct private equity or venture capital deals. Its primary capital deployment is into internal R&D, capital expenditures for its factories, and organic business expansion across its chemical, pharmaceutical, and agrochemical segments (per firm website, 2025).
What investment stages does Kureha typically target?
Kureha does not target external investment stages. Its activities are focused on the development, production, and sale of industrial chemicals, specialty materials, pharmaceuticals, and consumer goods. The company's strategic plans emphasize technology development and commercialization (per firm website, May 2026).
Which sectors does Kureha explicitly avoid?
Kureha does not participate in financial investments, private equity, venture capital, real estate development, or infrastructure finance. Its business is concentrated in industrial chemistry, pharmaceuticals, agrochemicals, and consumer packaging (per firm website, 2025).
How is Kureha related to Kureha Spinning or other group entities?
Kureha Corporation originated as the chemical division of Kureha Spinning, which itself was formed from the merger of former Kureha Cotton Spinning and other textile companies. Today, Kureha Spinning and Kureha Corporation are separate, unrelated entities. Kureha Corporation's official history notes the 1944 spin-off as its founding (per firm FAQ, 2025).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: